Found: 37
Select item for more details and to access through your institution.
Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid Malignancies.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 8, p. 1, doi. 10.1093/ofid/ofac417
- By:
- Publication type:
- Article
Clinical efficacy and safety of chimeric antigen receptor T‐cell therapy for mantle cell lymphoma with secondary central nervous system involvement.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 5, p. 774, doi. 10.1111/bjh.19037
- By:
- Publication type:
- Article
Checkpoint blockade treatment sensitises relapsed/refractory non‐Hodgkin lymphoma to subsequent therapy.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 1, p. 44, doi. 10.1111/bjh.16756
- By:
- Publication type:
- Article
Pembrolizumab in relapsed or refractory Richter syndrome.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 2, p. e117, doi. 10.1111/bjh.16762
- By:
- Publication type:
- Article
You have free access to this contentPD-1 inhibitor-related pneumonitis in lymphoma patients treated with single-agent pembrolizumab therapy.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 5, p. 752, doi. 10.1111/bjh.14441
- By:
- Publication type:
- Article
Minimal residual disease in non‐Hodgkin lymphoma – current applications and future directions.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 2, p. 177, doi. 10.1111/bjh.14996
- By:
- Publication type:
- Article
Next-generation sequencing-based detection of circulating tumour DNA After allogeneic stem cell transplantation for lymphoma.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 5, p. 841, doi. 10.1111/bjh.14311
- By:
- Publication type:
- Article
The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 1, p. 96, doi. 10.1111/bjh.13931
- By:
- Publication type:
- Article
A phase 2 study of Rituximab-Bendamustine and Rituximab-Cytarabine for transplant-eligible patients with mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 1, p. 89, doi. 10.1111/bjh.13929
- By:
- Publication type:
- Article
Detection of circulating tumour DNA in patients with aggressive B-cell non-Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 1, p. 123, doi. 10.1111/bjh.12439
- By:
- Publication type:
- Article
Refractory myeloid sarcoma with a FIP1L1-PDGFRA rearrangement detected by clinical high throughput somatic sequencing.
- Published in:
- Experimental Hematology & Oncology, 2015, v. 4, n. 1, p. 1, doi. 10.1186/s40164-015-0026-x
- By:
- Publication type:
- Article
Long-Term Reduction in Peripheral Blood HIV Type 1 Reservoirs Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation.
- Published in:
- Journal of Infectious Diseases, 2013, v. 207, n. 11, p. 1694, doi. 10.1093/infdis/jit086
- By:
- Publication type:
- Article
The Incidence of Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1785, doi. 10.3390/cancers13081785
- By:
- Publication type:
- Article
Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 6, p. 528, doi. 10.1001/jama.2023.11887
- By:
- Publication type:
- Article
Current Treatment Strategies in Acute Promyelocytic Leukemia.
- Published in:
- Current Medical Literature: Leukemia & Lymphoma, 2006, v. 14, n. 3, p. 61
- By:
- Publication type:
- Article
HL-398: Five-Year Overall Survival from the CheckMate 205 Study of Nivolumab for Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S373, doi. 10.1016/S2152-2650(21)01854-1
- By:
- Publication type:
- Article
Poster: HL-398: Five-Year Overall Survival from the CheckMate 205 Study of Nivolumab for Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S237, doi. 10.1016/S2152-2650(21)01489-0
- By:
- Publication type:
- Article
Hodgkin Lymphoma: What to Do When Checkpoint Inhibitors Fail.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S19, doi. 10.1016/S2152-2650(21)01194-0
- By:
- Publication type:
- Article
Classical Hodgkin Lymphoma Treatment Patterns, Molecular Profiling, and Clinical Outcomes in US Oncology Practices: A Prospective Observational Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S234, doi. 10.1016/j.clml.2018.07.117
- By:
- Publication type:
- Article
High-dose Thiotepa, Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplantation as Upfront Consolidation for Systemic Non-Hodgkin Lymphoma With Synchronous Central Nervous System Involvement.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Allogeneic Hematopoietic Cell Transplantation Outcomes After Nivolumab Monotherapy for Relapsed/Refractory Hodgkin Lymphoma (CA209-039 and CheckMate 205).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S326, doi. 10.1016/j.clml.2017.07.136
- By:
- Publication type:
- Article
Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitors.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00788-9
- By:
- Publication type:
- Article
Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease.
- Published in:
- Science Translational Medicine, 2013, v. 5, n. 179, p. 1, doi. 10.1126/scitranslmed.3005265
- By:
- Publication type:
- Article
The Emerging Role of Liquid Biopsies in Lymphoproliferative Disorders.
- Published in:
- Current Hematologic Malignancy Reports, 2019, v. 14, n. 1, p. 11, doi. 10.1007/s11899-019-0493-y
- By:
- Publication type:
- Article
Immune Checkpoint Blockade and Hematopoietic Stem Cell Transplant.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 1, p. 44, doi. 10.1007/s11899-017-0362-5
- By:
- Publication type:
- Article
Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 11, p. 1244, doi. 10.1002/ajh.25627
- By:
- Publication type:
- Article
White blood cell recovery after allogeneic hematopoietic cell transplantation predicts clinical outcome.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 6, p. 591, doi. 10.1002/ajh.23695
- By:
- Publication type:
- Article
Does iron overload really matter in stem cell transplantation?
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 6, p. 569, doi. 10.1002/ajh.23188
- By:
- Publication type:
- Article
Checkpoint Inhibitors in Lymphoma: A New Universe.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 1, p. 33
- By:
- Publication type:
- Article
High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 2, p. 226, doi. 10.1002/cncr.29023
- By:
- Publication type:
- Article
Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 5, p. 608, doi. 10.1111/bjh.12176
- By:
- Publication type:
- Article
Real‐World Characteristics, Treatment Patterns, Health Care Resource Use, and Costs of Patients with Diffuse Large B‐Cell Lymphoma in the U.S.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e817, doi. 10.1002/onco.13721
- By:
- Publication type:
- Article
Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy.
- Published in:
- Oncologist, 2020, v. 25, n. 10, p. 878, doi. 10.1634/theoncologist.2020-0167
- By:
- Publication type:
- Article
Outcomes and Toxicities of Programmed Death‐1 (PD‐1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real‐World, Multicenter Retrospective Analysis.
- Published in:
- Oncologist, 2019, v. 24, n. 7, p. 955, doi. 10.1634/theoncologist.2018-0538
- By:
- Publication type:
- Article
Autologous Stem Cell Transplantation in Elderly Lymphoma Patients in Their 70s: Outcomes and Analysis.
- Published in:
- Oncologist, 2018, v. 23, n. 5, p. 624, doi. 10.1634/theoncologist.2017-0499
- By:
- Publication type:
- Article
Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation: Report of 2 Cases.
- Published in:
- 2014
- By:
- Publication type:
- Case Study